AU1910792A - Pcp receptor ligands and the use thereof - Google Patents
Pcp receptor ligands and the use thereofInfo
- Publication number
- AU1910792A AU1910792A AU19107/92A AU1910792A AU1910792A AU 1910792 A AU1910792 A AU 1910792A AU 19107/92 A AU19107/92 A AU 19107/92A AU 1910792 A AU1910792 A AU 1910792A AU 1910792 A AU1910792 A AU 1910792A
- Authority
- AU
- Australia
- Prior art keywords
- receptor ligands
- pcp receptor
- pcp
- ligands
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69324491A | 1991-04-29 | 1991-04-29 | |
US693244 | 1991-04-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1910792A true AU1910792A (en) | 1992-12-21 |
Family
ID=24783901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19107/92A Abandoned AU1910792A (en) | 1991-04-29 | 1992-04-29 | Pcp receptor ligands and the use thereof |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0587670A4 (de) |
JP (1) | JPH07500571A (de) |
AU (1) | AU1910792A (de) |
CA (1) | CA2109420A1 (de) |
IE (1) | IE921392A1 (de) |
PT (1) | PT100431B (de) |
WO (1) | WO1992019621A1 (de) |
ZA (1) | ZA923119B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU662730B2 (en) * | 1991-02-20 | 1995-09-14 | American Home Products Corporation | Neuroprotectant agents |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025355A (en) | 1997-05-19 | 2000-02-15 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3597433A (en) * | 1968-08-19 | 1971-08-03 | Ayerst Mckenna & Harrison | 10,11 - dihydro - 5,10 - (iminomethano)-5h-dibenzo(a,d)cycloheptene and derivatives thereof |
US4940789A (en) * | 1989-10-10 | 1990-07-10 | American Home Products Corporation | 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents |
US5508401A (en) * | 1991-02-20 | 1996-04-16 | American Home Products Corporation | Substituted dibenzo[a,d]cycloheptene NMDA antagonists |
-
1992
- 1992-04-29 AU AU19107/92A patent/AU1910792A/en not_active Abandoned
- 1992-04-29 PT PT100431A patent/PT100431B/pt not_active IP Right Cessation
- 1992-04-29 ZA ZA923119A patent/ZA923119B/xx unknown
- 1992-04-29 WO PCT/US1992/003554 patent/WO1992019621A1/en not_active Application Discontinuation
- 1992-04-29 EP EP92911577A patent/EP0587670A4/de not_active Withdrawn
- 1992-04-29 CA CA002109420A patent/CA2109420A1/en not_active Abandoned
- 1992-04-29 JP JP4511463A patent/JPH07500571A/ja active Pending
- 1992-07-01 IE IE139292A patent/IE921392A1/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU662730B2 (en) * | 1991-02-20 | 1995-09-14 | American Home Products Corporation | Neuroprotectant agents |
Also Published As
Publication number | Publication date |
---|---|
CA2109420A1 (en) | 1992-10-30 |
IE921392A1 (en) | 1992-11-04 |
EP0587670A1 (de) | 1994-03-23 |
WO1992019621A1 (en) | 1992-11-12 |
ZA923119B (en) | 1993-01-27 |
PT100431A (pt) | 1993-08-31 |
PT100431B (pt) | 1999-08-31 |
EP0587670A4 (de) | 1995-02-01 |
JPH07500571A (ja) | 1995-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0714292A4 (de) | Sigma-rezeptor-liganden und ihre verwendung | |
AU1353997A (en) | Subtype-selective nmda receptor ligands and the use thereof | |
AU1463997A (en) | Subtype-selective nmda receptor ligands and the use thereof | |
AU8328691A (en) | Isocarbostiryl compounds and antitumor use thereof | |
AU9011491A (en) | Back bag | |
ZA926189B (en) | Beta-Phenylisoserine derivatives and their preparation and use. | |
AU2478492A (en) | Self-stabilised multiphase emusion structures | |
ZA929724B (en) | Ballisitc materials. | |
GB9127041D0 (en) | New use | |
AU1910792A (en) | Pcp receptor ligands and the use thereof | |
ZA933815B (en) | Pyrimidinyl- and triazinyl-salicyl- and -picolyl- amides and the use and preparation thereof. | |
AU1740692A (en) | New medicinal use | |
GB9000241D0 (en) | Pharmaceutical use | |
GB9101503D0 (en) | New use | |
GB9123204D0 (en) | New pharmaceutical use | |
GB9123203D0 (en) | New pharmaceutical use | |
GB9104306D0 (en) | New pharmaceutical use | |
GB9123202D0 (en) | New pharmaceutical use | |
GB9113943D0 (en) | New pharmaceutical use | |
GB9113918D0 (en) | New pharmaceutical use | |
GB9113850D0 (en) | New pharmaceutical use | |
GB9104307D0 (en) | New pharmaceutical use | |
AU2404092A (en) | Retinol-binding receptor and complex | |
GB9108747D0 (en) | New use | |
GB9121661D0 (en) | New use |